GREY:ICOTF - Post by User
Post by
DrHolidayon Jul 04, 2018 2:00pm
110 Views
Post# 28268189
Takeover offer or Partnership?
Takeover offer or Partnership?It wouldn't surprise me at all if the company was in partnership talks at this time,
for the express purpose of bringing Oral B Amphotericin to market as quickly as possible.
Such a partnership would help to fast-track phase 2 trial testing. It is now July, and ICO is on the radar of big pharma. Production, marketing and distribution rights could be granted to the right partner with the capital backing to develop this multi billion dollar market share worldwide.
Talk of a takeover at the 75 cent level would likely be rejected as insufficient given that Oral B Amphotericin is not the only drug in the development pipeline. Is this just a rumor or has someone spilled the beans? In any case, it would be advisable to keep such information very confidential before being made public.
ICO owns the patent rights, and is in control here.
You should all reread the DoubleBank recommendation that just came out.
Buckle your seatbelt, because this rocket is on the launchpad, and shorty will get squeezed big time and eaten alive by a lion.
DOC.